Taysha Gene Therapies, Inc. (TSHA)

5.21 -0.29 (-5.27%) USD  |  NASDAQ  |  Jan 02, 12:07
More

Taysha Gene Therapies Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for TSHA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
AngioDynamics, Inc. Upgrade
Anavex Life Sciences Corp. Upgrade
Bolt Biotherapeutics, Inc. Upgrade
Neurogene, Inc. Upgrade
Aspire Biopharma Holdings, Inc. Upgrade

Total Expenses (Quarterly) Related Metrics

Net Income (Quarterly) Upgrade
EPS Diluted (Quarterly) Upgrade
Enterprise Value Upgrade
Earnings Yield Upgrade
Normalized Earnings Yield Upgrade